Clinical Gastroenterology and Hepatology Review Time

Elsevier gives a very usable public timing surface for CGH.

The official page tells you:

• about 3 days to first decision
• about 39 days to decision after review
• about 96 days to acceptance
• about 43 days from acceptance to online publication
• the journal positions itself as an official clinical-practice journal of the AGA Institute

It does not tell you:

• a public median desk-rejection rate
• which article types move fastest or slowest
• how much quicker transfers from Gastroenterology may be in practice

So the best author model is still quick triage plus a multi-month reviewed path.

That is the practical planning range. CGH is efficient, but authors should not mistake that for instant publication.

CGH often feels fast because the editorial question is unusually concrete: is this immediately useful for GI clinical practice?

The journal can move quickly when:

• the patient-care consequence is obvious on page one
• the design is strong enough for the clinical claim
• the study reads like a GI practice paper rather than a mechanistic one
• the manuscript does not need a long explanation to justify why GI clinicians should care

Those papers are easier to route and easier to review.

The slower cases are often the papers that are clinically respectable but not cleanly owned by CGH.

Common sources of delay are:

• generic clinical relevance statements that do not change practice
• single-center cohorts making broad claims without enough validation
• mechanistic GI papers with only indirect bedside consequence
• revisions that must sharpen the practice implication or generalizability argument

That is why the journal can be fast at desk and still months-long in accepted cases.

That profile fits the timing posture. A journal at this level does not need to carry clinically vague papers through a long review cycle.

This matters because many timing frustrations are really owner-journal mistakes.

Directionally, the open citation signal is up from 5.19 in 2023 to 5.95 in 2024. That is consistent with CGH's stronger contemporary role as a high-trust clinical GI destination. Authors should read the timing model through that identity: fast clinical triage, then a serious but not endless review path.

Review-time data hides the key truth at CGH:

• a paper can be clinically respectable and still not be immediately useful enough for this journal
• a 3-day first decision is usually a fit judgment, not just admin speed
• the biggest timing variable is whether the manuscript changes GI practice clearly enough

That is why the better question is not only "how long?" It is "how clearly does this paper change GI decisions?"

In our pre-submission review work with CGH manuscripts, the timing mistake we see most often is authors assuming that any strong GI paper with some bedside language belongs here.

It does not.

The papers that move best here usually have:

• a patient-care consequence visible in the abstract
• design strength proportionate to the clinical claim
• fewer signs that the real story is mechanistic rather than clinical
• a clearer GI practice audience than a broader biomedical one

Those traits improve timing because they reduce the chance of a fast editorial stop or a revision cycle focused on proving the paper belongs here at all.

For CGH, speed matters less than clinical usefulness and owner fit.

That is why the better next reads are:

• Clinical Gastroenterology and Hepatology submission guide
• Clinical Gastroenterology and Hepatology impact factor
• How to avoid desk rejection at Clinical Gastroenterology and Hepatology
• How to choose the right journal for your paper

A CGH fit check is usually more useful than obsessing over the three-day first-decision number.

Clinical Gastroenterology and Hepatology review time is fast at the first gate and still meaningfully multi-month overall. The official public dashboard is clear enough to trust: quick triage, then about a three-month-plus path to acceptance for papers that survive.